https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
Seven days after ablation, total necrosis of the index tumor on MRI was obtained in eight (80% [95%CI 55%-100%]) patients. One patient was treated with radical prostatectomy. Re-biopsy at 6 months in the other 9 did not show evidence of cancer in 4 patients. IPSS, IIEF-5 and MSHQ-EjD-SF were not statistically different between baseline and 6 months follow up. OBT-fusion targeted FMA was feasible, precise, and safe in patients with low to intermediate risk localized prostate cancer. OBT-fusion targeted FMA was feasible, precise, and
Like
Comment
Share
